WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsHinge Health, Inc. (HNGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 1896% more annual revenue ($14.37B vs $720.06M). HNGE leads profitability with a 15.1% profit margin vs 2.5%. HNGE trades at a lower P/E of 11.5x. BTSG earns a higher WallStSmart Score of 55/100 (C).

BTSG

Buy

55

out of 100

Grade: C

Growth: 8.7Profit: 5.0Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.59

HNGE

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 6.0Value: 6.7Quality: 5.0
Piotroski: 3/9Altman Z: -2.69

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
196.6%10/10

Earnings expanding 196.6% YoY

Revenue GrowthGrowth
23.0%8/10

Revenue surging 23.0% year-over-year

HNGE3 strengths · Avg: 10.0/10
P/E RatioValuation
11.5x10/10

Attractively priced relative to earnings

Revenue GrowthGrowth
53.0%10/10

Revenue surging 53.0% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Areas to Watch

BTSG4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.5%3/10

2.5% margin — thin

Operating MarginProfitability
3.4%3/10

Operating margin of 3.4%

Debt/EquityHealth
1.173/10

Elevated debt levels

P/E RatioValuation
50.7x2/10

Premium valuation, high expectations priced in

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
21.5x2/10

Trading at 21.5x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 23.0% demonstrates continued momentum.

Bull Case : HNGE

The strongest argument for HNGE centers on P/E Ratio, Revenue Growth, Debt/Equity. Profitability is solid with margins at 15.1% and operating margin at 19.0%. Revenue growth of 53.0% demonstrates continued momentum.

Bear Case : BTSG

The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 50.7x leaves little room for execution misses. Thin 2.5% margins leave little buffer for downturns.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Key Dynamics to Monitor

HNGE is growing revenue faster at 53.0% — sustainability is the question.

HNGE generates stronger free cash flow (100M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BTSG scores higher overall (55/100 vs 52/100) and 23.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.

Visit Website →

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?